Standard

Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1. / Espinoza, Stefano; Ghisi, Valentina; Emanuele, Marco; Leo, Damiana; Sukhanov, Ilya; Sotnikova, Tatiana D.; Chieregatti, Evelina; Gainetdinov, Raul R.

In: Neuropharmacology, Vol. 93, 06.2015, p. 308-313.

Research output: Contribution to journalArticlepeer-review

Harvard

APA

Vancouver

Author

Espinoza, Stefano ; Ghisi, Valentina ; Emanuele, Marco ; Leo, Damiana ; Sukhanov, Ilya ; Sotnikova, Tatiana D. ; Chieregatti, Evelina ; Gainetdinov, Raul R. / Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1. In: Neuropharmacology. 2015 ; Vol. 93. pp. 308-313.

BibTeX

@article{706008baccfc4d96b2925a4ccdc2ba3a,
title = "Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1",
abstract = "Trace Amine-Associated Receptor 1 (TAAR1) is a G protein-coupled receptor (GPCR) known to modulate dopaminergic system through several mechanisms. Mice lacking this receptor show a higher sensitivity to dopaminergic stimuli, such as amphetamine; however, it is not clear whether D1 or D2 dopamine receptors and which associated intracellular signaling events are involved in this modulation. In the striatum of TAAR1 knock out (TAAR1-KO mice) we found that D2, but not D1, dopamine receptors were over-expressed, both in terms of mRNA and protein levels. Moreover, the D2 dopamine receptor-related G protein-independent AKT/GSK3 signaling pathway was selectively activated, as indicated by the decrease of phosphorylation of AKT and GSK3β. The decrease in phospho-AKT levels, suggesting an increase in D2 dopamine receptor activity in basal conditions, was associated with an increase of AKT/PP2A complex, as revealed by co-immunoprecipitation experiments. Finally, we found that the locomotor activation induced by the D2 dopamine receptor agonist quinpirole, but not by the full D1 dopamine receptor agonist SKF-82958, was increased in TAAR1-KO mice. These data demonstrate pronounced supersensitivity of postsynaptic D2 dopamine receptors in the striatum of TAAR1-KO mice and indicate that a close interaction of TAAR1 and D2 dopamine receptors at the level of postsynaptic structures has important functional consequences.",
keywords = "D2 receptor, Dopamine, Striatum, TAAR1",
author = "Stefano Espinoza and Valentina Ghisi and Marco Emanuele and Damiana Leo and Ilya Sukhanov and Sotnikova, {Tatiana D.} and Evelina Chieregatti and Gainetdinov, {Raul R.}",
note = "Publisher Copyright: {\textcopyright} 2015 Elsevier Ltd.",
year = "2015",
month = jun,
doi = "10.1016/j.neuropharm.2015.02.010",
language = "English",
volume = "93",
pages = "308--313",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1

AU - Espinoza, Stefano

AU - Ghisi, Valentina

AU - Emanuele, Marco

AU - Leo, Damiana

AU - Sukhanov, Ilya

AU - Sotnikova, Tatiana D.

AU - Chieregatti, Evelina

AU - Gainetdinov, Raul R.

N1 - Publisher Copyright: © 2015 Elsevier Ltd.

PY - 2015/6

Y1 - 2015/6

N2 - Trace Amine-Associated Receptor 1 (TAAR1) is a G protein-coupled receptor (GPCR) known to modulate dopaminergic system through several mechanisms. Mice lacking this receptor show a higher sensitivity to dopaminergic stimuli, such as amphetamine; however, it is not clear whether D1 or D2 dopamine receptors and which associated intracellular signaling events are involved in this modulation. In the striatum of TAAR1 knock out (TAAR1-KO mice) we found that D2, but not D1, dopamine receptors were over-expressed, both in terms of mRNA and protein levels. Moreover, the D2 dopamine receptor-related G protein-independent AKT/GSK3 signaling pathway was selectively activated, as indicated by the decrease of phosphorylation of AKT and GSK3β. The decrease in phospho-AKT levels, suggesting an increase in D2 dopamine receptor activity in basal conditions, was associated with an increase of AKT/PP2A complex, as revealed by co-immunoprecipitation experiments. Finally, we found that the locomotor activation induced by the D2 dopamine receptor agonist quinpirole, but not by the full D1 dopamine receptor agonist SKF-82958, was increased in TAAR1-KO mice. These data demonstrate pronounced supersensitivity of postsynaptic D2 dopamine receptors in the striatum of TAAR1-KO mice and indicate that a close interaction of TAAR1 and D2 dopamine receptors at the level of postsynaptic structures has important functional consequences.

AB - Trace Amine-Associated Receptor 1 (TAAR1) is a G protein-coupled receptor (GPCR) known to modulate dopaminergic system through several mechanisms. Mice lacking this receptor show a higher sensitivity to dopaminergic stimuli, such as amphetamine; however, it is not clear whether D1 or D2 dopamine receptors and which associated intracellular signaling events are involved in this modulation. In the striatum of TAAR1 knock out (TAAR1-KO mice) we found that D2, but not D1, dopamine receptors were over-expressed, both in terms of mRNA and protein levels. Moreover, the D2 dopamine receptor-related G protein-independent AKT/GSK3 signaling pathway was selectively activated, as indicated by the decrease of phosphorylation of AKT and GSK3β. The decrease in phospho-AKT levels, suggesting an increase in D2 dopamine receptor activity in basal conditions, was associated with an increase of AKT/PP2A complex, as revealed by co-immunoprecipitation experiments. Finally, we found that the locomotor activation induced by the D2 dopamine receptor agonist quinpirole, but not by the full D1 dopamine receptor agonist SKF-82958, was increased in TAAR1-KO mice. These data demonstrate pronounced supersensitivity of postsynaptic D2 dopamine receptors in the striatum of TAAR1-KO mice and indicate that a close interaction of TAAR1 and D2 dopamine receptors at the level of postsynaptic structures has important functional consequences.

KW - D2 receptor

KW - Dopamine

KW - Striatum

KW - TAAR1

UR - http://www.scopus.com/inward/record.url?scp=84924081435&partnerID=8YFLogxK

U2 - 10.1016/j.neuropharm.2015.02.010

DO - 10.1016/j.neuropharm.2015.02.010

M3 - Article

C2 - 25721394

AN - SCOPUS:84924081435

VL - 93

SP - 308

EP - 313

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

ER -

ID: 99380550